On Monday, President Trump announced that U.S. doctors may soon start warning pregnant women to avoid taking acetaminophen, better known as Tylenol.
“They are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary,” like for a fever that doesn’t settle quickly, said Trump.
Those in Opposition of President Trump’s Claim
The maker of Tylenol, Kenvue, has denied Trump’s recent claim, stating that their product is safe for pregnant women to take.
In a recent statement, Kenvue said, “We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned about the health risks and confusion this poses for expecting mothers and parents.”
Many health officials are also doubtful that autism is linked with Tylenol use during pregnancy. They cite that not only can autism be caused by several different factors, but there isn’t enough research to prove that Tylenol does, for certain, lead to an increased risk of autism.
Those Who Agree with President Trump’s Claim
A 2025 study conducted by Harvard University, however, concluded there’s enough evidence to suggest Tylenol exposure during pregnancy can be associated with an increased risk of neurodevelopmental disorders such as autism.
The study also agreed that “appropriate and immediate steps should be taken to advise pregnant women to limit acetaminophen consumption to protect their offspring’s neurodevelopment.”
Kush Desai, a spokesperson for the White House, is confident that Trump’s move will help the U.S. get a grip on soaring autism rates. Desai believes the “announcement will make historic progress.”
